A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Clinical trial NCT04008797 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04008797
Sponsor: Eisai Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Endometrial Neoplasms Neoplasms Carcinoma, Hepatocellular Liver Neoplasms Colorectal Neoplasms

Start date: 2019-07-11
Primary completion: 2027-03-31
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.